» Articles » PMID: 30174623

A Mini Review on the Contribution of the Anterior Cingulate Cortex in the Risk of Psychosis in 22q11.2 Deletion Syndrome

Overview
Specialty Psychiatry
Date 2018 Sep 4
PMID 30174623
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

22q11.2 deletion syndrome (22q11DS) is a neurogenetic disorder that causes a high risk of developing schizophrenia, thus representing a unique model for the investigation of biomarkers of psychosis. Cognitive and clinical risk factors have been identified as reliable predictors of schizophrenia in patients with 22q11DS and are currently used in the clinical practice. However, biomarkers based on neuroimaging are still lacking, mainly because of the analytic approaches adopted so far, which are almost uniquely based on the comparison of 22q11DS patients with healthy controls. Such comparisons do not take into account the heterogeneity within patients with 22q11DS, who indeed show various clinical manifestations. More recently, a number of studies compared measures of brain morphology and connectivity between patients with 22q11DS with different symptomatic profiles. The aim of this short review is to highlight the brain alterations found in patients with 22q11DS fulfilling ultra-high risk (UHR) criteria. Findings point to alterations in brain morphology and connectivity in frontal brain regions, and in particular in the anterior cingulate cortex, in patients with 22q11DS presenting UHR symptoms. These alterations may represent valuable biomarkers of psychosis in 22q11DS.

Citing Articles

Molecular and immunological origins of catatonia.

Beach S, Luccarelli J, Praschan N, Fusunyan M, Fricchione G Schizophr Res. 2023; 263:169-177.

PMID: 36966063 PMC: 10517087. DOI: 10.1016/j.schres.2023.03.013.


Opposing white matter microstructure abnormalities in 22q11.2 deletion and duplication carriers.

Seitz-Holland J, Lyons M, Kushan L, Lin A, Villalon-Reina J, Cho K Transl Psychiatry. 2021; 11(1):580.

PMID: 34759270 PMC: 8581007. DOI: 10.1038/s41398-021-01703-1.


Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.

Gur R, Roalf D, Alexander-Bloch A, McDonald-McGinn D, Gur R Curr Opin Genet Dev. 2021; 68:35-40.

PMID: 33571729 PMC: 8728946. DOI: 10.1016/j.gde.2021.01.007.


Structural control energy of resting-state functional brain states reveals less cost-effective brain dynamics in psychosis vulnerability.

Zoller D, Sandini C, Schaer M, Eliez S, Bassett D, Van De Ville D Hum Brain Mapp. 2021; 42(7):2181-2200.

PMID: 33566395 PMC: 8046160. DOI: 10.1002/hbm.25358.


Neuroimaging Phenotypes Associated With Risk and Resilience for Psychosis and Autism Spectrum Disorders in 22q11.2 Microdeletion Syndrome.

Jalbrzikowski M Biol Psychiatry Cogn Neurosci Neuroimaging. 2020; 6(2):211-224.

PMID: 33218931 PMC: 10234143. DOI: 10.1016/j.bpsc.2020.08.015.


References
1.
Fornito A, Yucel M, Dean B, Wood S, Pantelis C . Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull. 2008; 35(5):973-93. PMC: 2728810. DOI: 10.1093/schbul/sbn025. View

2.
. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

3.
Sandini C, Scariati E, Padula M, Schneider M, Schaer M, Van De Ville D . Cortical Dysconnectivity Measured by Structural Covariance Is Associated With the Presence of Psychotic Symptoms in 22q11.2 Deletion Syndrome. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 3(5):433-442. DOI: 10.1016/j.bpsc.2017.04.008. View

4.
Ramanathan S, Mattiaccio L, Coman I, Botti J, Fremont W, Faraone S . Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome. Schizophr Res. 2016; 188:35-41. DOI: 10.1016/j.schres.2016.11.041. View

5.
Schaer M, Debbane M, Cuadra M, Ottet M, Glaser B, Thiran J . Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr Res. 2009; 115(2-3):182-90. DOI: 10.1016/j.schres.2009.09.016. View